Effectiveness After Four and Twentyfour Weeks and Safety of Tocilizumab in Patients With Active RA.
Phase of Trial: Phase III
Latest Information Update: 26 Sep 2014
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Registrational; Therapeutic Use
- Sponsors Roche
- 10 Jun 2017 Biomarkers information updated
- 18 Dec 2009 Actual end date (Nov 2009) added as reported by ClinicalTrials.gov.
- 18 Dec 2009 Actual patient number (332) added as reported by ClinicalTrials.gov.